$BRFH
BARFRESH FOOD GROUP INC. Stock $brfh

$brfh Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000149315222032086 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$1.431M	$2.406M	$1.931M
YoY Change	-41.67%	24.63%	172.83%
Cost Of Revenue	$915.0K	$3.129M	$1.209M
YoY Change	-42.02%	158.72%	181.88%
Gross Profit	$516.0K	-$723.0K	$721.1K
YoY Change	-41.04%	-200.26%	158.88%
Gross Profit Margin	36.06%	-30.05%	37.35%
Selling, General & Admin	$1.502M	$1.873M	$1.031M
YoY Change	39.89%	81.69%	24.43%
% of Gross Profit	291.09%		142.96%
Research & Development	$35.00K	$220.0K	$34.45K
YoY Change	-51.19%	538.61%	-76.68%
% of Gross Profit	6.78%		4.78%
Depreciation & Amortization	$122.0K	$105.0K	$0.00
YoY Change	-26.5%		-100.0%
% of Gross Profit	23.64%		0.0%
Operating Expenses	$1.650M	$1.985M	$1.228M
YoY Change	25.82%	61.67%	10.12%
Operating Profit	-$1.134M	-$2.708M	-$506.7K
YoY Change	160.0%	434.48%	-39.42%
Interest Expense	$0.00
YoY Change	-100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$1.880M	-$2.708M	-$506.7K
YoY Change	-1543.16%	434.48%	-42.31%
Income Tax
% Of Pretax Income
Net Earnings	-$1.880M	-$2.708M	-$506.7K
YoY Change	-1543.16%	434.48%	-42.31%
Net Earnings / Revenue	-131.38%	-112.55%	-26.24%
Basic Earnings Per Share		-$0.21	-$0.04
Diluted Earnings Per Share	-$0.15	-$209.4K	-$39.30K
COMMON SHARES
Basic Shares Outstanding	12.93M shares	12.93M shares	12.89M shares
Diluted Shares Outstanding		12.93M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.808M	$2.837M	$6.261M
YoY Change	-49.25%	-54.69%	163.64%
Cash & Equivalents	$2.808M	$2.837M	$6.404M
Short-Term Investments
Other Short-Term Assets	$290.0K	$348.0K	$222.7K
YoY Change	40.78%	56.27%	-43.85%
Inventory	$1.048M	$602.0K	$1.178M
Prepaid Expenses
Receivables	$126.0K	$1.142M	$1.182M
Other Receivables	$101.0K	$77.00K	$0.00
Total Short-Term Assets	$4.373M	$5.006M	$8.843M
YoY Change	-42.96%	-43.39%	116.29%
LONG-TERM ASSETS
Property, Plant & Equipment	$389.0K	$1.241M	$1.840M
YoY Change	-75.5%	-32.57%	-16.9%
Goodwill
YoY Change
Intangibles	$306.0K	$323.0K
YoY Change	-17.3%
Long-Term Investments
YoY Change
Other Assets	$7.000K	$7.000K	$6.750K
YoY Change	0.0%	3.7%	-18.67%
Total Long-Term Assets	$720.0K	$1.607M	$2.233M
YoY Change	-64.91%	-28.05%	-16.24%
TOTAL ASSETS
Total Short-Term Assets	$4.373M	$5.006M	$8.843M
Total Long-Term Assets	$720.0K	$1.607M	$2.233M
Total Assets	$5.093M	$6.613M	$11.08M
YoY Change	-47.6%	-40.3%	63.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.033M	$1.802M	$1.418M
YoY Change	108.73%	27.06%	202.7%
Accrued Expenses	$286.0K	$315.0K	$757.8K
YoY Change	25.44%	-58.43%	23.74%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$51.65K
YoY Change			-16.79%
Total Short-Term Liabilities	$2.572M	$2.387M	$2.629M
YoY Change	72.04%	-9.2%	130.01%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$516.5K
YoY Change		-100.0%	-70.06%
Other Long-Term Liabilities	$0.00	$0.00	$39.32K
YoY Change	-100.0%	-100.0%	-86.27%
Total Long-Term Liabilities	$0.00	$0.00	$555.8K
YoY Change	-100.0%	-100.0%	-72.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.572M	$2.387M	$2.629M
Total Long-Term Liabilities	$0.00	$0.00	$555.8K
Total Liabilities	$2.572M	$2.387M	$3.185M
YoY Change	66.69%	-25.05%	0.96%
SHAREHOLDERS EQUITY
Retained Earnings	-$58.38M	-$56.50M
YoY Change	11.92%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.521M	$4.226M	$7.892M
YoY Change
Total Liabilities & Shareholders Equity	$5.093M	$6.613M	$11.08M
YoY Change	-47.6%	-40.3%	63.97%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$1.880M	-$2.708M	-$506.7K
YoY Change	-1543.16%	434.48%	-42.31%
Depreciation, Depletion And Amortization	$122.0K	$105.0K	$0.00
YoY Change	-26.5%		-100.0%
Cash From Operating Activities	-$29.00K	-$696.0K	-$410.0K
YoY Change	-96.22%	69.77%	-30.18%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	-$102.8K
YoY Change	-100.0%	-100.0%	642.63%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00	-$102.8K
YoY Change	-100.0%	-100.0%	642.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	-47.87K
YoY Change	-100.0%	-100.0%	-10.86%
NET CHANGE
Cash From Operating Activities	-29.00K	-696.0K	-410.0K
Cash From Investing Activities	0.000	0.000	-102.8K
Cash From Financing Activities	0.000	0.000	-47.87K
Net Change In Cash	-29.00K	-696.0K	-560.6K
YoY Change	-96.02%	24.15%	-14.38%
FREE CASH FLOW
Cash From Operating Activities	-$29.00K	-$696.0K	-$410.0K
Capital Expenditures	$0.00	$0.00	-$102.8K
Free Cash Flow	-$29.00K	-$696.0K	-$307.2K
YoY Change	-96.18%	126.57%	-46.42%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001487197
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2021Q4	us-gaap	Other Receivables OtherReceivables		usd
CY2022Q3	BRFH	Interest Payable Noncurrent InterestPayableNoncurrent		usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2021Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2022Q3	BRFH	Gain Loss On Extinguishment Of Debt For Paycheck Protection Program GainLossOnExtinguishmentOfDebtForPaycheckProtectionProgram		usd
CY2021Q3	BRFH	Gain Loss On Extinguishment Of Debt For Paycheck Protection Program GainLossOnExtinguishmentOfDebtForPaycheckProtectionProgram		usd
	BRFH	Gain Loss On Extinguishment Of Debt For Paycheck Protection Program GainLossOnExtinguishmentOfDebtForPaycheckProtectionProgram		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q3	us-gaap	Interest Expense InterestExpense		usd
CY2021Q3	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Interest Expense InterestExpense		usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	BRFH	Gain Loss On Extinguishment Of Debt For Paycheck Protection Program GainLossOnExtinguishmentOfDebtForPaycheckProtectionProgram		usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	BRFH	Net Carrying Value Of Convertible Notes And Accrued Interest Extinguished Through Issuance Of Stock NetCarryingValueOfConvertibleNotesAndAccruedInterestExtinguishedThroughIssuanceOfStock		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
	BRFH	Accrued Interest Paid In Stock AccruedInterestPaidInStock		usd
	BRFH	Equipment Included In Accounts Payable And Accrued Liability EquipmentIncludedInAccountsPayableAndAccruedLiability		usd
	BRFH	Extinguishment Of Derivative Liability ExtinguishmentOfDerivativeLiability		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41228
	dei	Entity Registrant Name EntityRegistrantName	BARFRESH FOOD GROUP INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-1994406
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3600 Wilshire Blvd.
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1720
	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90010
	dei	City Area Code CityAreaCode	310
	dei	Local Phone Number LocalPhoneNumber	598-7113
	dei	Entity Information Former Legal Or Registered Name EntityInformationFormerLegalOrRegisteredName	Not Applicable
	dei	Security12b Title Security12bTitle	Common stock, $0.000001 par value
	dei	Trading Symbol TradingSymbol	BRFH
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12934741	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2837000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5533000	usd
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	211000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	142000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1142000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1223000	usd
CY2022Q3	us-gaap	Other Receivables OtherReceivables	77000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	602000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	705000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	137000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	64000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	5006000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	7667000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1241000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1588000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	36000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	87000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	323000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	370000	usd
CY2022Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	7000	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	7000	usd
CY2022Q3	us-gaap	Assets Assets	6613000	usd
CY2021Q4	us-gaap	Assets Assets	9719000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1802000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	974000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	315000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	228000	usd
CY2022Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	231000	usd
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	212000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	39000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	81000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2387000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1495000	usd
CY2021Q4	BRFH	Interest Payable Noncurrent InterestPayableNoncurrent	34000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	14000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	2387000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	1543000	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.000001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.000001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	400000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	400000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.000001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.000001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	23000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	23000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12934741	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12934741	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12905112	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12905112	shares
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	60730000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	60341000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-56504000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-52165000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	4226000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8176000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6613000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9719000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2406000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1930000	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	1209000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7731000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4246000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	3129000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	6807000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2614000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	-723000	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	721000	usd
	us-gaap	Gross Profit GrossProfit	924000	usd
	us-gaap	Gross Profit GrossProfit	1632000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	815000	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	480000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2137000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1236000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1058000	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	586000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2736000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1598000	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	112000	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	163000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	390000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	456000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	1985000	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	1229000	usd
	us-gaap	Operating Expenses OperatingExpenses	5263000	usd
	us-gaap	Operating Expenses OperatingExpenses	3290000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2708000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-508000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4339000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1658000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	16000	usd
	BRFH	Gain Loss On Extinguishment Of Debt For Paycheck Protection Program GainLossOnExtinguishmentOfDebtForPaycheckProtectionProgram	568000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-194000	usd
	us-gaap	Interest Expense InterestExpense	128000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	262000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2708000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-508000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4339000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1396000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12931000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12892000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12920000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12143000	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Net Income Loss NetIncomeLoss	-4339000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1396000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	407000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	370000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	211000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	52000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	173000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	75000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	56000	usd
	BRFH	Gain Loss On Extinguishment Of Debt For Paycheck Protection Program GainLossOnExtinguishmentOfDebtForPaycheckProtectionProgram	568000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	16000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-194000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-81000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	757000	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	77000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-103000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	308000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	78000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	30000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	828000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1064000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	106000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	46000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-34000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	72000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2619000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1146000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	137000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-137000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6000000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	568000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	840000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5728000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2627000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4445000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5675000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1959000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3048000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6404000	usd
	BRFH	Amounts Included In Measurement Of Lease Liabilities AmountsIncludedInMeasurementOfLeaseLiabilities	60000	usd
	BRFH	Amounts Included In Measurement Of Lease Liabilities AmountsIncludedInMeasurementOfLeaseLiabilities	48000	usd
	BRFH	Net Carrying Value Of Convertible Notes And Accrued Interest Extinguished Through Issuance Of Stock NetCarryingValueOfConvertibleNotesAndAccruedInterestExtinguishedThroughIssuanceOfStock	467000	usd
	BRFH	Accrued Interest Paid In Stock AccruedInterestPaidInStock	151000	usd
	BRFH	Equipment Included In Accounts Payable And Accrued Liability EquipmentIncludedInAccountsPayableAndAccruedLiability	85000	usd
	BRFH	Extinguishment Of Derivative Liability ExtinguishmentOfDerivativeLiability	25000	usd
	us-gaap	Multiemployer Plan Increase In Employer Contribution Business Combination Percentage MultiemployerPlanIncreaseInEmployerContributionBusinessCombinationPercentage	0.58	pure
CY2022Q3	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	630000	usd
CY2022Q3	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	932000	usd
CY2021Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-13 reverse stock split
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_zOf1kEaboKti" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on information available as of the date of the financial statements; therefore, actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zZtNbfiOXPq" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Vendor Concentrations</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is exposed to supply risk as a result of concentrations in its vendor base resulting from the use of a limited number of contract manufacturers. Purchases from the Company’s contract manufacturers as a percent of all finished goods purchased were as follows:</span></p> <p id="xdx_899_eus-gaap--ScheduleOfProductInformationTableTextBlock_zCVFCumTZGR8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B7_zjoUwOHErk0e" style="display: none">Schedule of Company’s Contact Manufacturers of Finished Goods</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="6" style="text-align: center">For the three months ended September 30,</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="6" style="text-align: center">For the nine months ended September 30,</td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%; text-align: left">Manufacturer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220701__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--VendorMember__srt--MajorCustomersAxis__custom--ManufacturerAMember_zGGo0v49GGBh" style="width: 10%; text-align: right" title="Manufacturer percentage">54</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--VendorMember__srt--MajorCustomersAxis__custom--ManufacturerAMember_zBLfhScKOLBf" style="width: 10%; text-align: right" title="Manufacturer percentage">31</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--VendorMember__srt--MajorCustomersAxis__custom--ManufacturerAMember_zfVG93dT2eCb" style="width: 10%; text-align: right" title="Manufacturer percentage">58</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--VendorMember__srt--MajorCustomersAxis__custom--ManufacturerAMember_z2E0SnaVZS99" style="width: 10%; text-align: right" title="Manufacturer percentage">42</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Manufacturer B</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220701__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--VendorMember__srt--MajorCustomersAxis__custom--ManufacturerBMember_zbJLTvJOOnS1" style="text-align: right" title="Manufacturer percentage">31</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--VendorMember__srt--MajorCustomersAxis__custom--ManufacturerBMember_zMCVhN6pCaSb" style="text-align: right" title="Manufacturer percentage">32</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--VendorMember__srt--MajorCustomersAxis__custom--ManufacturerBMember_zXmRdebc7L41" style="text-align: right" title="Manufacturer percentage">28</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--VendorMember__srt--MajorCustomersAxis__custom--ManufacturerBMember_zIPswhDCRIl1" style="text-align: right" title="Manufacturer percentage">36</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Manufacturer C</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220701__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--VendorMember__srt--MajorCustomersAxis__custom--ManufacturerCMember_zyIoJOM09hcl" style="text-align: right" title="Manufacturer percentage">9</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--VendorMember__srt--MajorCustomersAxis__custom--ManufacturerCMember_zs7BUVt5DxOk" style="text-align: right" title="Manufacturer percentage">30</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--VendorMember__srt--MajorCustomersAxis__custom--ManufacturerCMember_z3gNmyk88q3i" style="text-align: right" title="Manufacturer percentage">8</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--VendorMember__srt--MajorCustomersAxis__custom--ManufacturerCMember_zlyXMdRpshY2" style="text-align: right" title="Manufacturer percentage">15</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Manufacturer D</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220701__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--VendorMember__srt--MajorCustomersAxis__custom--ManufacturerDMember_zcmtTENIlET4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Manufacturer percentage">6</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--VendorMember__srt--MajorCustomersAxis__custom--ManufacturerDMember_zdc3LgAwu884" style="border-bottom: Black 1.5pt solid; text-align: right" title="Manufacturer percentage">7</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--VendorMember__srt--MajorCustomersAxis__custom--ManufacturerDMember_zgdATjaAVHY1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Manufacturer percentage">6</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--VendorMember__srt--MajorCustomersAxis__custom--ManufacturerDMember_zxzjBTyaJkRf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Manufacturer percentage">7</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220701__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--VendorMember__srt--MajorCustomersAxis__custom--ManufacturerMember_zXc8kAU4EQL4" style="border-bottom: Black 2.5pt double; text-align: right" title="Manufacturer percentage">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--VendorMember__srt--MajorCustomersAxis__custom--ManufacturerMember_zMIX6PGgSfzh" style="border-bottom: Black 2.5pt double; text-align: right" title="Manufacturer percentage">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--VendorMember__srt--MajorCustomersAxis__custom--ManufacturerMember_zwZAy98ZaWte" style="border-bottom: Black 2.5pt double; text-align: right" title="Manufacturer percentage">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--VendorMember__srt--MajorCustomersAxis__custom--ManufacturerMember_zT6QqovaA1Pa" style="border-bottom: Black 2.5pt double; text-align: right" title="Manufacturer percentage">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p id="xdx_8AA_zbE0HSCxQHHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	121000	usd
CY2022Q3	BRFH	Shipping And Handling Costs ShippingAndHandlingCosts	450000	usd
CY2021Q3	BRFH	Shipping And Handling Costs ShippingAndHandlingCosts	316000	usd
	BRFH	Shipping And Handling Costs ShippingAndHandlingCosts	1208000	usd
	BRFH	Shipping And Handling Costs ShippingAndHandlingCosts	717000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	220000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	34000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	347000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	173000	usd
CY2022Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	40000	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	105000	usd
CY2022Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	562000	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	600000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	602000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	705000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3851000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3836000	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3256000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2894000	usd
CY2022Q3	BRFH	Property Plant And Equipment PropertyPlantAndEquipment	595000	usd
CY2021Q4	BRFH	Property Plant And Equipment PropertyPlantAndEquipment	942000	usd
CY2022Q3	BRFH	Equipment Not Yet Placed In Service EquipmentNotYetPlacedInService	646000	usd
CY2021Q4	BRFH	Equipment Not Yet Placed In Service EquipmentNotYetPlacedInService	646000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1241000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1588000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	105000	usd
CY2021Q3	us-gaap	Depreciation Depreciation	147000	usd
	us-gaap	Depreciation Depreciation	360000	usd
	us-gaap	Depreciation Depreciation	407000	usd
	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	10000	usd
	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	18000	usd
CY2021Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	25000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	16000	usd
CY2021Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	25000	usd
	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2023-03-31
CY2021Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	20000	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	20000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	60000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	60000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	36000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	20000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	20000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	40000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	39000	usd
	us-gaap	Legal Fees LegalFees	100000	usd
	BRFH	Stock Issued During Period Value Interest Paid In Shares StockIssuedDuringPeriodValueInterestPaidInShares	151000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	2324000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6000000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	685000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	52000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1396000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	75000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	7891000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8176000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8176000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	211000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	173000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4339000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	4226000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	4226000	usd
CY2022Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	102852	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	8.82
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	5000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	625016	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.55
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y9M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	56980	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.90
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	17644	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	5.08
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	664352	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.38
	BRFH	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P3Y2M12D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	577242	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	7.64
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y8M12D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.848	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.021	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	4.53
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	180000	usd
	BRFH	Unrecognized Sharebased Compensation Weighted Average Period UnrecognizedSharebasedCompensationWeightedAveragePeriod	P2Y2M12D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	41554	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.27
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	4631	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	5.38
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	36923	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.25
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2619000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1146000	usd
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	3048000	usd

Files In Submission

Name	View Source	Status
0001493152-22-032086-index-headers.html	Edgar Link	pending
0001493152-22-032086-index.html	Edgar Link	pending
0001493152-22-032086.txt	Edgar Link	pending
0001493152-22-032086-xbrl.zip	Edgar Link	pending
brfh-20220930.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
brfh-20220930_def.xml	Edgar Link	unprocessable
brfh-20220930_lab.xml	Edgar Link	unprocessable
brfh-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
brfh-20220930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BRFH
BARFRESH FOOD GROUP INC. Stock $brfh

2022 Q4 Form 10-Q Financial Statement

#000149315222032086 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BRFH BARFRESH FOOD GROUP INC. Stock $brfh

2022 Q4 Form 10-Q Financial Statement

#000149315222032086 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BRFH
BARFRESH FOOD GROUP INC. Stock $brfh